Characterization of clinical strains of Aspergillus terreus complex: Molecular identification and antifungal susceptibility to azoles and amphotericin B

Clinical Microbiology and Infection

Volumn 18, Issue 2, 2012, Pages

  Escribano, P ^a,b   Pelaez T ^a,b,c   Recio, S ^a   Bouza, E ^a,b,c   Guinea, J ^a,b,c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c SCHOOL OF MEDICINE   (Spain)

Author keywords

Amphotericin B; Antifungal susceptibility; Aspergillus terreus; Azoles; Molecular identification

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS TERREUS; EPSILOMETER TEST; FUNGAL STRAIN; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ASPERGILLUS TERREUS;

EID: 84856213796     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03714.x     Document Type: Article

References (18)

1. Balajee SA, Gribskov JL, Hanley E, Nickle D, Marr KA. Aspergillus lentulus sp. Nov., a new sibling species of A. fumigatus. Eukaryot Cell 2005; 4: 625-632.
2. Varga J, Houbraken J, Van Der Lee HA, Verweij PE, Samson RA. Aspergillus calidoustus sp. Nov., causative agent of human infections previously assigned to Aspergillus ustus. Eukaryot Cell 2008; 7: 630-638.
3. Vinh DC, Shea YR, Sugui JA et al. Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis 2009; 49: 102-111.
4. Baddley JW, Pappas PG, Smith AC, Moser SA. Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 2003; 41: 5525-5529.
5. Balajee SA, Kano R, Baddley JW et al. Molecular identification of Aspergillus species collected for the transplant-associated infection surveillance network. J Clin Microbiol 2009; 47: 3138-3141.
6. Lass-Florl C, Griff K, Mayr A et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 2005; 131: 201-207.
7. Blum G, Perkhofer S, Grif K et al. A 1-year Aspergillus terreus surveillance study at the university hospital of Innsbruck: molecular typing of environmental and clinical isolates. Clin Microbiol Infect 2008; 14: 1146-1151.
8. Varga J, Toth B, Kocsube S et al. Evolutionary relationships among Aspergillus terreus isolates and their relatives. Antonie Van Leeuwenhoek 2005; 88: 141-150.
9. Balajee SA, Baddley JW, Peterson SW et al. Aspergillus alabamensis, a new clinically relevant species in the section terrei. Eukaryot Cell 2009; 8: 713-722.
10. Auberger J, Lass-Florl C, Clausen J et al. First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation. Diagn Microbiol Infect Dis 2008; 62: 336-339.
11. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis 2008; 46: 1813-1821.
12. White TJ, Burns T, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gefland DH, Sninsky JJ, White TJ, eds. PCR protocols: a guide to methods and applications. San Diego, CA: Academic Press, 1990; 315-322.
13. Balajee SA, Borman AM, Brandt ME et al. Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol 2009; 47: 877-884.
14. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-425.
15. Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 1993; 10: 512-526.
16. Tamura K, Dudley J, Nei M, Kumar S. Mega 4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-1599.
17. Blum G, Perkhofer S, Haas H et al. Potential basis for amphotericin B resistance in Aspergillus terreus. Antimicrob Agents Chemother 2008; 52: 1553-1555.
18. Lass-Florl C, Kofler G, Kropshofer G et al. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 1998; 42: 497-502.